Effective Pharmacological Treatment of Painful Diabetic Neuropathy by Nurse Practitioners: Results of an Algorithm-Based Experience

Pain Medicine (United States)

Volumn 13, Issue 10, 2012, Pages 1324-1333

  Geerts, Margot ^a   Landewé Cleuren, Sabine A N T ^a   Kars, Marleen ^a   Vrijhoef, Hubertus J M ^b   Schaper, Nicolaas C ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b TILBURG UNIVERSITY   (Netherlands)

Author keywords

Chronic pain; Diabetic neuropathy; Patient satisfaction

Indexed keywords

AMITRIPTYLINE; DULOXETINE; PREGABALIN; TRAMADOL;

ALGORITHM; ANALGESIA; ANXIETY; ARTICLE; DEPRESSION; DIABETIC NEUROPATHY; DISEASE SEVERITY; DRUG WITHDRAWAL; ENDOCRINOLOGIST; GENERAL PRACTITIONER; HUMAN; MAJOR CLINICAL STUDY; MOOD; NEUROPATHIC PAIN; NURSE PRACTITIONER; OUTPATIENT DEPARTMENT; PATIENT CARE; PATIENT SATISFACTION; PRESCRIPTION; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

EID: 84867652848     PISSN: 15262375     EISSN: 15264637     Source Type: Journal    
DOI: 10.1111/j.1526-4637.2012.01469.x     Document Type: Article

References (38)

1. Boulton AJ, Vinik AI, Arezzo JC, etal. Neuropathies, a statement by the American Diabetes Association. Diabetes Care 2005;28:956-62.
2. Ziegler D. Treatment of diabetic neuropathy and neuropathic pain: How far have we come? Diabetes Care 2008;31:255-61.
3. Daousi C, MacFarlane IA, Woodward A, etal. Chronic painful peripheral neuropathy in an urban community: A controlled comparison of people with and without diabetes. Diabet Med 2004;21:976-82.
4. Herman WH, Kennedy L. Underdiagnosis of peripheral neuropathy in type 2 diabetes. Diabetes Care 2005;28:1480-1.
5. Meyer-Rosberg K, Kvarnstrom A, Kinnman E, etal. Peripheral neuropathic pain-A multidimensional burden for patients. Eur J Pain 2001;5:379-89.
6. Vileikyte L, Rubin RR, Leventhal H. Psychological aspects of diabetic neuropathic foot complications: An overview. Misconceptions, assessment of patient beliefs and behaviour, illness perception at the individual level. Diabetes Metab Res Rev 2004;20:13-8.
7. Benbow SJ, Wallymahmed ME, MacFarlane IA. Diabetic peripheral neuropathy and quality of life. Q J Med 1998;91:733-7.
8. Davies M, Brophy S, Wiliams R, Taylor A. The prevalence, severity and impact of painful diabetic peripheral neuropathy in type 2 diabetes. Diabetes Care 2006;29:1518-22.
9. Gore M, Brandenburg NA, Hoffman DL, Tai KS, Stacey B. Burden of illness in painful diabetic peripheral neuropathy: The patients' perspectives. J Pain 2006;7:892-900.
10. Hoffman DL, Sadosky A, Dukes EM, Alvir J. How do changes in pain severity levels correspond to changes in health status and function in patients with painful diabetic peripheral neuropathy? Pain 2010;149(2):194-201.
11. Farrar JT, Young JJP, LaMoreaux L, etal. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain 2001;94:149-58.
12. Jude EB, Schaper NC. Treating painful diabetic polyneuropathy. BMJ 2007;335:57-8.
13. Jensen TS, Backonja MM, Hernández Jiménez S, etal. New perspectives on the management of diabetic peripheral neuropathic pain. Diab Vasc Dis Res 2006;3:108-19.
14. Geerts M, Bours GJJW, de Wit R, etal. Prevalence and impact of pain in diabetic neuropathy. Eur Diabetes Nurs 2009;6(2):58-64.
15. van Eijk-Hustings YJ, Daemen L, Schaper NC, Vrijhoef HJ. Implementation of Motivational Interviewing in a diabetes care management initiative in The Netherlands. Patient Educ Couns 2011;84(1):10-5.
16. Cook TD, Campbell DT. Quasi-Experimentation. Design & Analysis Issues for Field Settings. Chicago, IL: Rand McNally College Publishing Company; 1979.
17. Dworkin RH, Backonja M, Rowbotham MC, etal. Advances in neuropathic pain: Diagnosis, mechanisms and treatment recommendations. Arch Neurol 2003;60:1524-34.
18. Zelman DC, Gore M, Dukes E, etal. Validation of a modified version of the Brief Pain Inventory for painful diabetic peripheral neuropathy. J Pain Symptom Manage 2005;29:401-10.
19. Keller S, Bann CM, Dodd SL, etal. Validity of the brief pain inventory for use in documenting the outcomes of patients with noncancer pain. Clin J Pain 2004;20:309-18.
20. Dworkin R, Nagasako E, Galer B. Assessment of Neuropathic Pain. Handbook of Pain Assessment. New York: Guilford Press; 2002.
21. Breuer B, Pappagallo M, Knotkova H, etal. A randomized, double-blind, placebo-controlled, two-period, crossover, pilot trial of lamotrigine in patients with central pain due to multiple sclerosis. Clin Ther 2007;29(9):2022-30.
22. Ware JE, Kosinkski M, Keller SD. SF-12 How to Score the SF-12 Physical and Mental Health Summary Scales. Lincoln, RI: QualityMetric Incorporated; 1998.
23. Johnston M, Pollard B, Hennessey P. Construct validation of the Hospital Anxiety and Depression Scale with clinical populations. J Psychosom Res 2000;48:579-84.
24. Spinhoven P, Ormel J, Sloekers P, etal. A validation study of the Hospital Anxiety and Depression Scale (HADS) in different groups of Dutch subjects. Psychol Med 1997;27:363-70.
25. Glasgow RE, Wagner EH, Schaefer J, etal. Development and validation of the Patient Assessment of Chronic Illness Care (PACIC). Med Care 2005;43:436-44.
26. McGlynn EA. An evidence-based national quality measurement and reporting system. Med Care 2003;41:I8-15.
27. Morris J, Coyle D. Quality of life questionnaires in cancer clinical trials: Imputing missing values. Psychooncology 1994;3(3):215-22.
28. Valk GD, de Sonaville JJ, van Houtum WH, etal. The assessment of diabetic polyneuropathy in daily clinical practice: Reproducibility and validity of Semmes Weinstein monofilaments examination and clinical neurological examination. Muscle Nerve 1997;20:116-8.
29. Anderson KO. Role of cutpoints: Why grade pain intensity? Pain 2005;113:5-6.
30. Tölle T, Xu X, Sadosky AB. Painful diabetic neuropathy: A cross-sectional survey of health state impairment and treatment patterns. J Diabetes Complications 2006;20:26-33.
31. Kaasalainen S, Martin-Misener R, Carter N, etal. The nurse practitioner role in pain management in long-term care. J Adv Nurs 2010;66(3):542-51.
32. Finnerup NB, Otto M, McQuay HJ, etal. Algorithm for neuropathic pain treatment: An evidence based proposal. Pain 2005;118:289-305.
33. DaCosta DiBonaventura M, Cappelleri JC, Joshi AV. A longitudinal assessment of painful diabetic peripheral neuropathy on health status, productivity, and health care utilization and cost. Pain Med 2011;12(1):118-26.
34. Vrijhoef HJ, Berbee R, Wagner EH, etal. Quality of integrated chronic care measured by patient survey: Identification, selection and application of most appropriate instruments. Health Expect 2009;12(4):417-29.
35. Institute of Medicine. Crossing the Quality Chasm: A New Health System for the 21st Century. Washington, DC: National Academy Press; 2001.
36. Brownlee S, Leventhal EA, Leventhal H. Regulation, self-regulation and regulation of the self in maintaining physical health. In: Boekartz M, Pintrich PR, Zeidner M, eds. Handbook of Self-Regulation. San Diego, CA: Academic; 2000:369-416.
37. Matthias MS, Parpart AL, Nyland KA, etal. The patient-provider relationship in chronic pain care: Providers' perspectives. Pain Med 2010;11(11):1688-97.
38. Frantsve LM, Kerns RD. Patient-provider interactions in the management of chronic pain: Current findings within the context of shared medical decision making. Pain Med 2007;8:25-35.